Abstract

The possibilities of using sodium-glucose cotransporter type 2 inhibitors in the treatment of patients with cardiovascular diseases (literature review)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call